Purgation is given with trivrit triphala and danti in liquid form to see the efficacy of drugs in the psoriasis
Not Applicable
Completed
- Conditions
- Health Condition 1: L409- Psoriasis, unspecifiedHealth Condition 2: L409- Psoriasis, unspecified
- Registration Number
- CTRI/2020/04/024586
- Lead Sponsor
- Dr Priyanka Dhiman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
1.Patients who are fit for virechana karma
2.Between the age group of 18-60 years
3.Patients who are willing to participate and sign informed consent form
4.Patient who are fulfilling all the diagnostic criteria
Exclusion Criteria
1.Patients with complications of psoriasis
2.Cases of diabetes mellitus, hypertension, HIV, HBsAg, carcinoma
3.Subjects with impaired cardiac function,impaired hepatic function, impaired hepatic function
4.Signs of systemic infections
5.Pregnant women and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effectiveness will be evaluated by the relief seen in sign and symptomsTimepoint: outcome will be assessed after 14 days
- Secondary Outcome Measures
Name Time Method OT APPLICABLETimepoint: NOT APPLICABLE